Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a beneficial ownership of 8.8% in Tenet Healthcare Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 13.3% beneficial ownership stake in Teradata Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.0% Stake in Alcoa Corporation
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.0% beneficial ownership stake in Alcoa Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Stake in Allient Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 5.9% of Allient Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.7% of ATI INC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Stake in Arcellx, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.4% of Arcellx, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.4% Passive Stake in Arcus Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% passive beneficial ownership stake in Arcus Biosciences Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.5% Stake in Beam Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.5% in Beam Therapeutics Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.3% in Beazer Homes USA Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.7% Stake in Chewy, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 5.7% of Chewy, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 6.7% beneficial ownership stake in Coursera, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has reported a 12.2% beneficial ownership stake in Dream Finders Homes, Inc.'s Class A Stock as of March 31, 2025, held for investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in First Interstate Bancsystem, Reports 6.3% Passive Ownership
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, disclosing a 6.3% beneficial ownership stake in First Interstate Bancsystem Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Fortive Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 7.8% Passive Stake in Fox Corp Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership of Fox Corp's Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.2% Passive Stake in Freeport-McMoRan Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in Freeport-McMoRan Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.8% Stake in Guidewire Software
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 9.8% beneficial ownership stake in Guidewire Software, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.3% beneficial ownership stake in Health Catalyst, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a 6.7% beneficial ownership stake in Hess Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 7.3% beneficial ownership stake in Hilton Worldwide Holdings Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.1% Stake in IDEAYA Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.1% of IDEAYA Biosciences Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, disclosing a 9.4% beneficial ownership stake in IDEXX Laboratories Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.3% beneficial ownership stake in INOVIO PHARMACEUTICALS INC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.2% Passive Stake in Intellia Therapeutics
BlackRock, Inc. has filed an updated Schedule 13G, revealing a passive beneficial ownership of 8.2% of Intellia Therapeutics, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Intercontinental Exchange, Disclosing 6.8% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 12 to Schedule 13G, disclosing its beneficial ownership of 6.8% of Intercontinental Exchange, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Passive Stake in iShares Core MSCI International Developed Markets ETF
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 5.9% of the common stock in the iShares Core MSCI International Developed Markets ETF as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.3% of Kimball Electronics Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.6% beneficial ownership stake in MarketAxess Holdings Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.7% passive beneficial ownership stake in Mersana Therapeutics Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 12 to its Schedule 13G, reaffirming its passive beneficial ownership of 6.7% of Mosaic Co.'s common stock as of March 31, 2025.